APOE and neurodegenerative disease: Healthy, nonimpaired APOE ε4 carriers have a systemic pro-inflammatory phenotype17 (and as we have shown here), early signs of BBB disruption45, alterations in brain activity and connectivity53,54, and sleep disturbances55, all of which are known to be risk factors for neurodegenerative diseases, broadly56–58.